Abstracts Experimental Studies; Animal Tumors

Total Page:16

File Type:pdf, Size:1020Kb

Abstracts Experimental Studies; Animal Tumors ABSTRACTS EXPERIMENTAL STUDIES; ANIMAL TUMORS of ’ Discussion on Experimental Production Malignant Turnours, J. A. MURRAY et al. Proc. Roy. SOC.,London, Series B 113: 268-292, 1933. In opening this discussion Dr. Murray pointed out that many of the ideas and conclusions resulting from pathologic study of malignant tumors have obtained precision and validity from the Atudy of the transplantable and experimental tumors of animals during the past thirty years. We can now with some confidence define malignant tumors as tissue proliferations arising in a localized area, growing from their own resources in an uncontrolled manner, and showing a continuous graded series in those arising from any one tissue. We are still without a satis- factory explanation of the process which embraces all the characters of neoplasia, and it is impossible to accept any hypothesis of its nature and origin which omits any of these characters. Theories of carcinogenesis may be divided into three groups. (I) The first of these is the genetic or mutation hypothesis, originating yith Boveri. (2) The virus hypothesis is at present inadmissible because cell-free transmission of mam- malian tumors has not yet been demonstrated. Until this is accomplished it is dangerous to transfer conceptions arising from the study of filtrable avian neo- plasms to the elucidation of the nature and causation of tumors in other animals and in man. (3) The experimental confirmation of Virchow’s chronic irritation theory has established its validity as a concise description of the emergence of cancer after prolonged, localized, slight irritation of tissue by a variety of agents, and nothing more. The experimental induction of malignant tumors reproduces perfectly the phenomena which occur in the development of occupationd cancer from exposure to tar, x-rays, etc. Wide differences of opinion still find expression as to how this result is brought about. It is possible that the chemical and physicaI carcinogenic agents act indirectly by setting up conditions in the tissues such that here and there cancerous foci are started, but the properties of these agents are so varied as to give no indication of how the uncontrolled type of pro- liferation is induced, or of the nature of the cellular mechanism involved. Until this difficulty is at least partially overcome, it seems useless to indulge in the further speculation that the less precisely known carcinogenic agents (application of cold, x-rays, etc.) produce this effect by liberating in the tissues subshnces more or less closely related chemically to one or other of the pure substances with car- cinogenic action. Dr. W. J. Cook, confining his remarks to the experimental production of cancer by pure chemical compounds, pointed out that chronic irritation ” is a misleading term. There are many examples of industrial skin diseases brought about by chemical irritation, but few of these lead to malignant tumor formation. There are many constituents of coal tar which are powerful irritants and yet are not carcinogenic. On the other hand, not one of the carcinogenic hydrocarbons has any apparent irritating effect on the skin. No view of the origin of malignant disease can lie comprehensive if it fails to take into account the cancer-producing properties of all the known carcinogenic agents. Experimental investigation of the effect of these agents on tissue metabolism is of importance. Boyland, for instance, has found that carcinogenic hydrocarbons influence enzyme systems in a manner similar to arsenious acid, which is undoubtedly responsible for cases of 141 142 ABSTRACTS human cancer. A factor common to all the carcinogenic hydrocarbons is the presence of the phenanthrene ring system, which is also contained in a number of naturally occurring compounds of biologic interest, such as the sterols, the ovarian hormone, possibly the male hormone, vitamin D, etc. Dr. W. Cramer remarked that the close chemical relationship between certain carcinogenic substances and the sterols, which are constituents of every animal cell, suggests that normal cells, if placed under abnormal conditions, can themselves produce carcinogenic substances as abnormal metabolites. The conditions vaguely called chronic irritation may act in this manner. Another and quite different method of inducing carcinogenesis is the trans-, mission of tumors by cell-free filtrates containing an agent which is thermolabile and can give rise to antibodies. This immediate and specific type of carcinogenesis has so far been observed only in birds, and produces only tumors of mesoblastic origin. Spontaneous tumors in fowls, as in mammals, appear in middle-aged or old individuals, and do not spread among healthy birds by contagion; experimental transmission by filtrates is effected more easily in young than in old birds. Work on mammalian tumors has led to the conclusion that the change which constitutes malignancy is a purely cellular one, not due to an extraneous agent, and that it probably resides in the nucleus. Bauer’s suggestion that this change affects the genes, so that the cancer cell represents a mutation of a normal somatic cell, is merely an interesting guess, which does not enable us to understand the character- istic properties of the malignant cell, such as its infiltrative growth and altered metabolism. Warburg’s work seems to offer a better explanation of malignant cell growth than do the conceptions of a virus or a mutation. The changed metabolism makes the cancer cell more independent of an available oxygen supply than the normal cell from which it is derived. But whatever explanation of the intracellular change we may adopt, we still have to explain why the normal cells of one and the same organism can give rise to such varied manifestations of malignancy, each of which breeds true. The.essentia1 features of cancer have been fixed by experimental study and are not affected, whatever may be found to be the intimat,e cellular change. If cancer is a mutation, we cannot mutate back at will; if it is an intracellular virus we can not kill the virus within the cell; an immune system capable of neutralizing completely an active extract of Rous sarcoma has no effect whatever on the cells of this tumor. The correction of an abnormal type of metabolism offers greater therapeutic possibilities, but so far attempts along this line have not been RUC- cessful. Dr. C. E. Andrewes expressed his opinion that the filtrable fowl tumorR afford an important line of attack on the tumor problem as a whole. It is difficult to believe that the fowl sarcomas are essentially and entirely different in nature from mammalian tumors, and to maintain the attitude that these filtrable tumors form a group of virus diseases quite different from fowl tumors as a whole. Whenever a fowl tumor has been studied over a long period, it has proved to be filtrable. If the virus theory of cancer is worth considering seriously, we should also be pre- pared to accept the principle that the viruses that cause tumors are probably not sharply distinguishable from those causing infections. There are various patho- logic conditions which many cancer workers dismiss from consideration as not being true tumors, yet these stand in an intermediate position between the tumors and the infections. Examples are the lymphosarcoma of dogs, the myxoma of rabbits, and Shope’s interesting filtrable fibroma of the rabbit [see Am. J. Cancer 17: 808, 809, 19331, the agent of which apparently behaves at one time like a tumor producer and at another causes an inflammatory reaction bearing no resem- blance to a tumor. EXPERIMENTAL 8TUDIEB ; ANIMAL TUMORS 143 Dr. P. R. Peacock agreed that the filtrable avian tumors and their relationship to mammalian tumors present a probIem which must be solved before generaliza- tions as to the causation of tumor growth can be regarded as more than interesting speculations. An obvious method seems to be the induction of tumors in fowls by agents which produce tumors in mammals, and it is surprising that so far only about a dozen such tumors have been described, only one of which has been carried beyond the second generation. This tumor, produced in Murphy's laboratory, was carried through eleven generations of transplantation, but was never shown to be filtrable. But inability to do something is not. proof that it cannot be done. Peacock had found no real difficulty in producing tumors in fowls by injecting carcinogenic tars intramuscularly, provided the birds could be kept alive for from six months to a year. The tumors thus obtained were not distinguishable clinically or histologically from some of the filtrable tumors, such as the Rous sarcoma. These tumors could be propagated, though with difficulty. [See Abst. in Am. J. Cancer 17: 969, 1933.1 Prof. J. McIntosh prefaced his remarks by saying that we have many theories, but more definite facts are required; " the birth,of a fact is the death of a theory." He had obtained tumors in 12 out of 20 birds treated with tar, and even in this mmall number there was considerable histologic variety. Some were fibrosarco- matous, others mainly fibro-endotheliomatous; in others these types were asso- ciated with leukosarcoma or leukemia. Three of these different types of tar tumors were carried through one or more passages. One, a fibrosarcoma, originally a leukemia with only a fibrous reaction in the breast muscle, has been carried through six passages and now breeds true, having lost the leukemic element, and it is readily fltrabie. That these tumors were of spontaneous origin seems nega- tived by the fact that before these tarring experiments began, during seven years only one spontaneous tumor had been found among more than 5000 birds used. The work of Ellerman, Furth and others on the leukemias of birds hau shown that there is a good deal of pleomorphism in the type of disease produced by inoculation of a leukemic virus; for instance, Furth, in propagating a single strain of leukosis in a large series of birds, found that at one time or another it gave rise to erythro- leukosis, lymphoid leukosis, myeloid leukosis, a combination of myeloid leukosis and erythroleukosis, myeloma, and sarcoma.
Recommended publications
  • Supraclavicular Artery Island Flap in Head and Neck Reconstruction
    European Annals of Otorhinolaryngology, Head and Neck diseases 132 (2015) 291–294 View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Available online at ScienceDirect www.sciencedirect.com Technical note Supraclavicular artery island flap in head and neck reconstruction a b a,c a,∗,c S. Atallah , A. Guth , F. Chabolle , C.-A. Bach a Service de chirurgie ORL et cervico-faciale, hôpital Foch, 40 rue Worth, 92150 Suresnes, France b Service de radiologie, hôpital Foch, 40, rue Worth, 92150 Suresnes, France c Université de Versailles Saint-Quentin en Yvelines, UFR de médecine Paris Ouest Saint-Quentin-en-Yvelines, 78280 Guyancourt, France a r t i c l e i n f o a b s t r a c t Keywords: Due to the complex anatomy of the head and neck, a wide range of pedicled or free flaps must be available Supraclavicular artery island flap to ensure optimal reconstruction of the various defects resulting from cancer surgery. The supraclavi- Fasciocutaneous flap cular artery island flap is a fasciocutaneous flap harvested from the supraclavicular and deltoid regions. Head and neck cancer The blood supply of this flap is derived from the supraclavicular artery, a direct cutaneous branch of the Reconstructive surgery transverse cervical artery in 93% of cases or the supraclavicular artery in 7% of cases. The supraclavicular artery is located in a triangle delineated by the posterior border of the sternocleidomastoid muscle medi- ally, the external jugular vein posteriorly, and the median portion of the clavicle anteriorly.
    [Show full text]
  • Phenacetin Acts As a Weak Genotoxic Compound Preferentially in the Kidney of DNA Repair Deficient Xpa Mice
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis Volume 596, Issues 1-2 , 11 April 2006, Pages 143-150 doi:10.1016/j.mrfmmm.2005.12.011 Copyright © 2006 Elsevier B.V. All rights reserved. Phenacetin acts as a weak genotoxic compound preferentially in the kidney of DNA repair deficient Xpa mice Mirjam Luijtena,*, Ewoud N. Speksnijdera, Niels van Alphena, Anja W estermana, Siem H. Heisterkampb, Jan van Benthema, Coen F. van Kreijla, Rudolf B. Beemsa and Harry van Steega aLaboratory of Toxicology, Pathology and Genetics, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands bCentre for Information Technology and Methodology, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands Abstract Chronic use of phenacetin-containing analgesics has been associated with the development of renal cancer. To establish genotoxicity as a possible cause for the carcinogenic effect of phenacetin, we exposed wild type and DNA repair deficient XpaÞ/Þ and XpaÞ/Þ/Trp53+/Þ mice (further referred as Xpa and Xpa/p53 mice, respectively), carrying a reporter lacZ gene, to 0.75% (w/w) phenacetin mixed in feed. Xpa mice completely lack the nucleotide excision repair pathway, and as such they are sensitive to some classes of genotoxic compounds. Phenacetin exposure induced a significant increase of lacZ mutations in the kidney of both Xpa and Xpa/p53 mice. A minor response was found in liver, whereas no lacZ mutation induction was observed in the spleen of these animals. Interestingly, the observed phenacetin-induced mutant frequencies were higher in male than those found in female mice.
    [Show full text]
  • A Pocket Manual of Percussion And
    r — TC‘ B - •' ■ C T A POCKET MANUAL OF PERCUSSION | AUSCULTATION FOB PHYSICIANS AND STUDENTS. TRANSLATED FROM THE SECOND GERMAN EDITION J. O. HIRSCHFELDER. San Fbancisco: A. L. BANCROFT & COMPANY, PUBLISHEBS, BOOKSELLEBS & STATIONEB3. 1873. Entered according to Act of Congress, in the year 1872, By A. L. BANCROFT & COMPANY, Iii the office of the Librarian of Congress, at Washington. TRAN jLATOR’S PREFACE. However numerou- the works that have been previously published in the Fi 'lish language on the subject of Per- cussion and Auscultation, there has ever existed a lack of a complete yet concise manual, suitable for the pocket. The translation of this work, which is extensively used in the Universities of Germany, is intended to supply this want, and it is hoped will prove a valuable companion to the careful student and practitioner. J. 0. H. San Francisco, November, 1872. PERCUSSION. For the practice of percussion we employ a pleximeter, or a finger, upon which we strike with a hammer, or a finger, producing a sound, the character of which varies according to the condition of the organs lying underneath the spot percussed. In order to determine the extent of the sound produced, we may imagine the following lines to be drawr n upon the chest: (1) the mammary line, which begins at the union of the inner and middle third of the clavicle, and extends downwards through the nipple; (2) the paraster- nal line, which extends midway between the sternum and nipple ; (3) the axillary line, which extends from the centre of the axilla to the end of the 11th rib.
    [Show full text]
  • Acral Manifestations of Soft Tissue Tumors Kristen M
    Clinics in Dermatology (2017) 35,85–98 Acral manifestations of soft tissue tumors Kristen M. Paral, MD, Vesna Petronic-Rosic, MD, MSc⁎ Section of Dermatology, University of Chicago Pritzker School of Medicine, Chicago, IL Abstract This group of biologically diverse entities is united by topographic localization to the hands and feet. Categorizing tumors by body site narrows the differential into a short list of possibilities that can facil- itate accurate and rapid diagnosis. The goal of this review is to provide a practical approach to soft tissue tumors of acral locations for clinicians, pathologists, and researchers alike. What ensues in the following text is that tight coupling of the clinical picture and histopathologic findings should produce the correct diagno- sis, or at least an abbreviated differential. The salient clinicopathologic, immunohistochemical, and molec- ular features are presented alongside current treatment recommendations for each entity. © 2017 Elsevier Inc. All rights reserved. Introduction actin (SMA) and are deemed “myofibroblasts.”1 The tumors under this heading express combinations of CD34, FXIIIa, fi The entities presented herein are categorized on the basis of and SMA. The synthesis of collagen by broblasts translates fi fi morphogenesis (where possible) and by biologic potential as to a brous consistency that clinically imparts a rm texture benign, intermediate, and malignant neoplasms. on palpation, and, macroscopically, a gray-white or white-tan cut surface. The entities discussed next have no metastatic po- tential; that is, simple excision is adequate. Fibrous and related tissues: Benign lesions Fibroma of tendon sheath fi fl The ontogenetic classi cation of benign lesions re ects appar- Also known as tenosynovial fibroma, compared with other fi fi fi ent broblastic or broblast-like morphogenesis.
    [Show full text]
  • Abdominal Examination
    PACES- Abdomen Adel Hasanin Ahmed STATION 1 - ABDOMEN STEPS OF EXAMINATION (1) APPROACH THE PATIENT Read the instructions carefully for clues Approach the right hand side of the patient, shake hands, introduce yourself Ask permission to examine him “I am just going to feel your tummy, if it is all right with you” Position patient lying flat on the bed with one pillow supporting the head (but not the shoulder) and arms rested alongside the body Expose the whole abdomen and chest including inguinal regions (breasts can remain covered in ladies) (2) GENERAL INSPECTION STEPS POSSIBLE FINDINGS 1. Scan the patient. Palpate for glandular breast Nutritional status: under/average built or overweight tissue in obese subjects if gynaecomastia is Abnormal Facies: Cushingoid (steroid therapy in renal suspected disease or post renal transplant), bronzing/slate-grey skin (haemochromatosis) Skin marks: Spider naevi (see theoretical notes), scratch marks, purpura, bruises, vitiligo (autoimmune disease) Decreased body hair (in face and chest for males and in axilla and pubic hair for both sexes) Gynaecomastia A-v fistula 2. Examine the eyes: pull down the eyelid. Xanthelasma (primary biliary cirrhosis). Anaemia (pallor) in the conjunctivae at the guttering between the eyeball and the lower lid Check the sclera for icterus Kayser-Fleischer rings (see theoretical notes) 3. Examine the mouth: Central cyanosis (in the under-surface of the tongue) . look at the lips Cheilosis/angular cheilitis (swollen cracked bright-red lips in . Ask the patient to evert his lips (inspect iron, folate, vitamin B12 or B6 deficiency) the inner side of the lips) Abnormal odour of breath (see theoretical notes) .
    [Show full text]
  • Renal Pyelocalyceal Squamous Cell Carcinoma in a Patient with An
    Güler et al. Journal of Medical Case Reports (2019) 13:154 https://doi.org/10.1186/s13256-019-2090-z CASEREPORT Open Access Renal pyelocalyceal squamous cell carcinoma in a patient with an ectopic kidney presenting with chronic pyelonephritis: a case report Yavuz Güler1*, Burak Üçpınar2 and Akif Erbin2 Abstract Background: Until now, few cases of pelvis squamous cell carcinoma in various renal anomalies have been reported. To our knowledge, primary squamous cell carcinoma arising from a pelvic ectopic kidney has never been described. In this report, we describe a case of renal pyelocalyceal squamous cell carcinoma in a patient with an ectopic kidney presenting with chronic pyelonephritis. Case summary: A 73-year-old Caucasian woman presented to our hospital with pyelonephritis symptoms. Abdominopelvic computed tomography revealed heterogeneous and irregular minimal contrast enhancement in the pelvic ectopic kidney parenchyma. Radiologists reported that the images were consistent with chronic pyelonephritis. A Tc-99m dimercaptosuccinic acid renal scan demonstrated a nonfunctioning right pelvic ectopic kidney. The patient underwent open simple nephrectomy via modified Gibson incision. The whole mass was a distended, saclike structure without any grossly visible renal tissue. Pathological examination showed renal pelvis squamous cell carcinoma 8 cm in diameter infiltrating into the renal capsule and perinephritic fatty tissue. The patient was staged as T4N0M1 renal pelvis squamous cell carcinoma. The patient was being treated in the intensive care unit for respiratory distress on the seventh day after the operation. By the first-month follow-up visit, the patient had died of acute respiratory distress syndrome. Conclusions: Although rare, renal pelvis squamous cell carcinoma should be considered in the differential diagnosis of a renal mass in patients who have renal anomalies and chronic pyelonephritis.
    [Show full text]
  • Pathology and Genetics of Tumours of Soft Tissue and Bone
    bb5_1.qxd 13.9.2006 14:05 Page 3 World Health Organization Classification of Tumours WHO OMS International Agency for Research on Cancer (IARC) Pathology and Genetics of Tumours of Soft Tissue and Bone Edited by Christopher D.M. Fletcher K. Krishnan Unni Fredrik Mertens IARCPress Lyon, 2002 bb5_1.qxd 13.9.2006 14:05 Page 4 World Health Organization Classification of Tumours Series Editors Paul Kleihues, M.D. Leslie H. Sobin, M.D. Pathology and Genetics of Tumours of Soft Tissue and Bone Editors Christopher D.M. Fletcher, M.D. K. Krishnan Unni, M.D. Fredrik Mertens, M.D. Coordinating Editor Wojciech Biernat, M.D. Layout Lauren A. Hunter Illustrations Lauren A. Hunter Georges Mollon Printed by LIPS 69009 Lyon, France Publisher IARCPress International Agency for Research on Cancer (IARC) 69008 Lyon, France bb5_1.qxd 13.9.2006 14:05 Page 5 This volume was produced in collaboration with the International Academy of Pathology (IAP) The WHO Classification of Tumours of Soft Tissue and Bone presented in this book reflects the views of a Working Group that convened for an Editorial and Consensus Conference in Lyon, France, April 24-28, 2002. Members of the Working Group are indicated in the List of Contributors on page 369. bb5_1.qxd 22.9.2006 9:03 Page 6 Published by IARC Press, International Agency for Research on Cancer, 150 cours Albert Thomas, F-69008 Lyon, France © International Agency for Research on Cancer, 2002, reprinted 2006 Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention.
    [Show full text]
  • Application of Percutaneous Osteoplasty in Treating Pelvic Bone Metastases: Efficacy and Safety
    Cardiovasc Intervent Radiol (2019) 42:1738–1744 https://doi.org/10.1007/s00270-019-02320-8 CLINICAL INVESTIGATION NON-VASCULAR INTERVENTIONS Application of Percutaneous Osteoplasty in Treating Pelvic Bone Metastases: Efficacy and Safety 1 1 1 1 1 He-Fei Liu • Chun-Gen Wu • Qing-Hua Tian • Tao Wang • Fei Yi Received: 17 October 2018 / Accepted: 20 August 2019 / Published online: 23 September 2019 Ó Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2019 Abstract 1.87 ± 1.46 at 6 months (P \ 0.05), 1.90 ± 1.47 at Background Percutaneous vertebroplasty has been a good 9 months (P \ 0.05), and 1.49 ± 1.17 at 12 months option to treat vertebral metastases. The pelvic bone is a (P \ 0.05). The ODI also changed after the procedure, common site of spread for many cancers. Using follow-up with significant differences between baseline scores and at data for 126 patients, we evaluated the safety and efficacy each follow-up examination (P \ 0.05). Pain relief was of percutaneous osteoplasty (POP) to treat pelvic bone achieved in 118 patients (93.65%); however, pain relief metastases. was not obvious in seven patients (5.56%), and pain was Materials and Methods In this retrospective study, 126 aggravated in one patient (0.79%). Extraosseous cement patients (mean age 57.45 ± 11.46 years old) with 178 leakage occurred in 35 patients (27.78%) without causing lesions were treated using POP. The visual analog scale any clinical complications. (VAS), Oswestry Disability Index (ODI), and the changes Conclusion Percutaneous osteoplasty is a safe and effec- in the patient’s use of painkillers were used to evaluate pain tive choice for patients with painful osteolytic pelvic bone and quality of life before the procedure, and at 3 days and metastases.
    [Show full text]
  • Mast Cell Infiltration and Leukotriene
    Journal of Cancer Therapy, 2015, 6, 606-612 Published Online July 2015 in SciRes. http://www.scirp.org/journal/jct http://dx.doi.org/10.4236/jct.2015.67066 Mast Cell Infiltration and Leukotriene Receptor Expression in Various Tumors: Possible Clinical Application of Common Pathological Findings Concerned with Tumor Development Masao Sugamata*, Tomomi Ihara, Miho Sugamata Department of Pathology, Tochigi Institute of Clinical Pathology, Tochigi, Japan Email: *[email protected] Received 18 June 2015; accepted 18 July 2015; published 21 July 2015 Copyright © 2015 by authors and Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/ Abstract Since the mechanisms of the developmental processes of tumors remain unclear, early detection and early treatment of the tumors is necessary to save patients with malignant tumors. Therapies currently available to patients are surgery, chemotherapy, and radiotherapy. However, there are many patients who cannot be saved by such therapies. In this study, we found the common fea- tures of various tumor tissues, and we demonstrated the effect of therapeutics that target them by using experimental rats with spontaneous tumors. 26 kinds of human tumors (epithelial or me- senchymal origin, and malignant or benign) and Sprague-Dawley rats with spontaneous mammary gland tumors were examined by light and electron microscope. To detect of mast cells and leuko- triene receptor, toluidine blue stain and immunohistochemical stain were performed. The rats were orally administered one of leukotriene receptor antagonists. We found that the presence of numerous mast cells and expression of leukotriene receptors in various tumor (human tumors and rat spontaneous tumors).
    [Show full text]
  • A Case of Incidental Schwannoma Mimicking Necrotic Metastatic Lymph Node from Bladder Cancer
    medicina Case Report A Case of Incidental Schwannoma Mimicking Necrotic Metastatic Lymph Node from Bladder Cancer Jeong-Hyouk Choi 1, Koo-Han Yoo 1 , Dong-Gi Lee 1, Gyeong-Eun Min 1 , Gou-Young Kim 2 and Tae-Soo Choi 1,* 1 Department of Urology, College of Medicine, Kyung Hee University, Seoul 05278, Korea; [email protected] (J.-H.C.); [email protected] (K.-H.Y.); [email protected] (D.-G.L.); [email protected] (G.-E.M.) 2 Department of Pathology, College of Medicine, Kyung Hee University, Seoul 05278, Korea; [email protected] * Correspondence: [email protected]; Tel.: +82-2-440-6271; Fax: +82-2-440-7744 Abstract: Background and Objectives: Retroperitoneal schwannoma is a very rare case of schwan- noma which commonly occurs in the other part of the body. However, it is difficult to distinguish schwannoma from other tumors before pathological examination because they do not show specific characteristics on imaging study such as ultrasound, computed tomography (CT), and magnetic reso- nance image (MRI). Case summary: A 60-year-old male showed a retroperitoneal cystic tumor which is found incidentally during evaluation of coexisted bladder tumor. Neurogenic tumor was suspicious for the retroperitoneal tumor through pre-operative imaging study. Finally, a schwannoma was diagnosed by immunohistochemical examination after complete surgical excision laparoscopically. Conclusion: As imaging technology is developed, there may be more chances to differentiate schwan- Citation: Choi, J.-H.; Yoo, K.-H.; Lee, noma from other neoplasm. However, still surgical resection and histopathological examination is D.-G.; Min, G.-E.; Kim, G.-Y.; Choi, feasible for diagnosis of schwannoma.
    [Show full text]
  • A Gastrointestinal Stromal Tumor Presenting As a Pelvic Mass: a Case Report
    899-902 4/3/2009 11:12 Ì ™ÂÏ›‰·899 ONCOLOGY REPORTS 21: 899-902, 2009 899 A gastrointestinal stromal tumor presenting as a pelvic mass: A case report ROBERTO ANGIOLI1, CLEONICE BATTISTA1, LUDOVICO MUZII1, GIOVANNA MADONNA TERRACINA1, ESTER VALENTINA CAFÀ1, MARIA ISABELLA SERENI1, ROBERTO MONTERA1, FRANCESCO PLOTTI2, CARLA RABITTI1 and PIERLUIGI BENEDETTI PANICI2 1Department of Obstetrics and Gynecology ‘Campus Biomedico’ University of Rome, Via Alvaro del Portillo 200, 00128 Rome; 2Department of Obstetrics and Gynecology ‘La Sapienza’ University of Rome, V.le del Policlinico 155, 00161 Rome, Italy Received March 18, 2008; Accepted September 19, 2008 DOI: 10.3892/or_00000301 Abstract. Gastrointestinal stromal tumors (GISTs) represent include the gallbladder or bladder (5). In terms of distribution, 0.1-1% of gastrointestinal malignancies. They are commonly 50-60% of lesions arise in the stomach, 20-30% in the small asymptomatic and found incidentally during laparoscopy, bowel, 10% in the large bowel, 5% in the oesophagus and 5% surgical procedures or radiological studies. Diagnosis is elsewhere in the abdominal cavity (5-7). based on histology and immunohistochemistry, while the role Diagnosis is based on histology and immunohisto- of imaging studies is not diagnosis-specific. We present the chemistry. In the past, GISTs were considered to be part of GI case of a 38-year-old patient complaining of an increase in leiomyomas, leiomyosarcomas, leiomyoblastomas and the her abdominal circumference. Consequently, a vaginal schwannomas group (Table I) as a result of their histological examination, a transvaginal ultrasound and an MRI of the findings and apparent origin in the muscolaris propria layer of abdomen and pelvis were carried out.
    [Show full text]
  • Hypofractionated Irradiation of Infra
    Guenzi et al. Radiation Oncology (2015) 10:177 DOI 10.1186/s13014-015-0480-y RESEARCH Open Access Hypofractionated irradiation of infra-supraclavicular lymph nodes after axillary dissection in patients with breast cancer post-conservative surgery: impact on late toxicity Marina Guenzi1, Gladys Blandino1*, Maria Giuseppina Vidili3, Deborah Aloi1, Elena Configliacco1, Elisa Verzanini1, Elena Tornari1, Francesca Cavagnetto2 and Renzo Corvò1 Abstract Background: The aim of the present work was to analyse the impact of mild hypofractionated radiotherapy (RT) of infra-supraclavicular lymph nodes after axillary dissection on late toxicity. Methods: From 2007 to 2012, 100 females affected by breast cancer (pT1- T4, pN1-3, pMx) were treated with conservative surgery, Axillary Node Dissection (AND) and loco-regional radiotherapy (whole breast plus infra-supraclavicular fossa). Axillary lymph nodes metastases were confirmed in all women. The median age at diagnosis was 60 years (range 34–83). Tumors were classified according to molecular characteristics: luminal-A 59pts(59%),luminal-B24pts(24%),basal-like10pts(10%),Her-2like7pts(7%).82pts(82%)received hormonal therapy, 9 pts (9 %) neo-adjuvant chemotherapy, 81pts (81 %) adjuvant chemotherapy. All patients received a mild hypofractionated RT: 46 Gy in 20 fractions 4 times a week to whole breast and infra- supraclavicular fossa plus an additional weekly dose of 1,2 Gy to the lumpectomy area. The disease control and treatment related toxicity were analysed in follow-up visits. The extent of lymphedema was analysed by experts in Oncological Rehabilitation. Results: Within a median follow-up of 50 months (range 19–82), 6 (6 %) pts died, 1 pt (1 %) had local progression disease, 2 pts (2 %) developed distant metastasis and 1 subject (1 %) presented both.
    [Show full text]